GADO, FRANCESCA
GADO, FRANCESCA
Dipartimento di Scienze Farmaceutiche
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors
2024 M. Di Stefano, S. Masoni, G. Bononi, G. Poli, S. Galati, F. Gado, S. Manzi, C. Vagaggini, A. Brai, I. Caligiuri, K. Asif, F. Rizzolio, M. Macchia, A. Chicca, A. Sodi, V. Di Bussolo, F. Minutolo, P. Meier, J. Gertsch, C. Granchi, E. Dreassi, T. Tuccinardi
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
2024 G. Baron, A. Altomare, L. Della Vedova, F. Gado, O. Quagliano, S. Casati, N. Tosi, L. Bresciani, D. Del Rio, G. Roda, A. D'Amato, C. Lammi, A. Macorano, S. Vittorio, G. Vistoli, L. Fumagalli, M. Carini, A. Leone, M. Marino, C. Del Bo’, G. Miotto, F. Ursini, P. Morazzoni, G. Aldini
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
2023 R. Ferrisi, B. Polini, C. Ricardi, F. Gado, K.A. Mohamed, G. Baron, S. Faiella, G. Poli, S. Rapposelli, G. Saccomanni, G. Aldini, G. Chiellini, R.B. Laprairie, C. Manera, G. Ortore
The Department’s green heart, from the Botanic Garden to ethnobotany
2023 M. Bottoni, F. Milani, G. Baron, F. Gado, E. Sabato, L. Colombo, P. Sira Colombo, P. Bruschi, G. Vistoli, G. Aldini, C. Giuliani, G. Fico
Chemical, Nutritional and Biological Evaluation of a Sustainable and Scalable Complex of Phytochemicals from Bergamot By-Products
2023 L. Della Vedova, F. Gado, T.A. Vieira, N.A. Grandini, T.L.N. Palácio, J.S. Siqueira, M. Carini, E. Bombardelli, C.R. Correa, G. Aldini, G. Baron
Targeting Nrf2 and NF-κB Signaling Pathways in Cancer Prevention: The Role of Apple Phytochemicals
2023 F. Gado, G. Ferrario, L. DELLA VEDOVA, B. Zoanni, A.A. Altomare, M. Carini, G. Aldini, A. D'Amato, G. Baron
Identification of new GSK3β inhibitors through a consensus machine learning-based virtual screening
2023 S. Galati, M. Di Stefano, S. Bertini, C. Granchi, A. Giordano, F. Gado, M. Macchia, T. Tuccinardi, G. Poli
The interplay between cannabinoid receptors and microglia in the pathophysiology of Alzheimer's disease
2023 R. Ferrisi, F. Gado, C. Ricardi, B. Polini, C. Manera, G. Chiellini
Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet
2022 J. Silva Siqueira, T. Aparecida Vieira, E. Tiemi Nakandakare-Maia, T. Luiz Novaga Palacio, F. Sarzi, J. Leite Garcia, B. Henrique de Paula, S. Garcia Zanati Bazan, G. Baron, L. Tucci, E. Janda, A.A. Altomare, F. Gado, A. Junio Togneri Ferron, G. Aldini, F. Valentini Francisqueti-Ferron, C. Renata Correa
Polyphenols from Thinned Young Apples: HPLC-HRMS Profile and Evaluation of Their Anti-Oxidant and Anti-Inflammatory Activities by Proteomic Studies
2022 G. Ferrario, G. Baron, F. Gado, L. DELLA VEDOVA, E. Bombardelli, M. Carini, A. D'Amato, G. Aldini, A.A. Altomare
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators
2022 F. Gado, C. Ceni, R. Ferrisi, G. Sbrana, L.A. Stevenson, M. Macchia, R.G. Pertwee, S. Bertini, C. Manera, G. Ortore
Achillea moschata Wulfen: From Ethnobotany to Phytochemistry, Morphology, and Biological Activity
2022 M. Bottoni, G. Baron, F. Gado, F. Milani, L. Santagostini, L. Colombo, P. Sira Colombo, E. Caporali, A. Spada, M. Biagi, C. Giuliani, P. Bruschi, G. Aldini, G. Fico
Liquid Chromatography–High-Resolution Mass Spectrometry (LC-HRMS) Profiling of Commercial Enocianina and Evaluation of Their Antioxidant and Anti-Inflammatory Activity
2022 L. DELLA VEDOVA, G. Ferrario, F. Gado, A.A. Altomare, M. Carini, P. Morazzoni, G. Aldini, G. Baron
Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: Signaling and cytokines release in blood mononuclear cells
2022 A. Capozzi, D. Caissutti, V. Mattei, F. Gado, S. Martellucci, A. Longo, S. Recalchi, V. Manganelli, G. Riitano, T. Garofalo, M. Sorice, C. Manera, R. Misasi
Synthesis and In Vitro Characterization of Selective Cannabinoid {CB}2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
2022 F. Gado, R. Ferrisi, S. Di Somma, F. Napolitano, K.A. Mohamed, L.A. Stevenson, S. Rapposelli, G. Saccomanni, G. Portella, R.G. Pertwee, R.B. Laprairie, A. Maria Malfitano, C. Manera
Design, Synthesis, and Biological Activity of New {CB}2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
2022 F. Gado, R. Ferrisi, B. Polini, K.A. Mohamed, C. Ricardi, E. Lucarini, S. Carpi, F. Domenichini, L.A. Stevenson, S. Rapposelli, G. Saccomanni, P. Nieri, G. Ortore, R.G. Pertwee, C. Ghelardini, L. Di Cesare Mannelli, G. Chiellini, R.B. Laprairie, C. Manera
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
2022 R. Ferrisi, F. Gado, B. Polini, C. Ricardi, K.A. Mohamed, L.A. Stevenson, G. Ortore, S. Rapposelli, G. Saccomanni, R.G. Pertwee, R.B. Laprairie, C. Manera, G. Chiellini
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
2021 F. Gado, K.A. Mohamed, S. Meini, R. Ferrisi, S. Bertini, M. Digiacomo, F. D'Andrea, L.A. Stevenson, R.B. Laprairie, R.G. Pertwee, C. Manera
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases
2021 R. Ferrisi, C. Ceni, S. Bertini, M. Macchia, C. Manera, F. Gado
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
2021 L. Shapiro, F. Gado, C. Manera, A. Escayg